Intelligence Feed event · Equity · 2026-10-07

    Neogen Beats Q1 Estimates with $222.8M Revenue and $0.08 Adjusted EPS

    Question

    Neogen Beats Q1 Estimates with $222.8M Revenue and $0.08 Adjusted EPS

    Direct answer

    Neogen posted first-quarter fiscal 2026 financial results that surpassed expectations on both top and bottom lines. Net revenue grew 6.5% year-over-year to $222.8 million, beating the $208.09 million consensus estimate by 7.07%. Diluted earnings per share came in at $0.08, delivering a 60% upside surprise relative to the $0.05 consensus estimate. The outperformance reflects strengthening volume trends and integration progress in the Food Safety division.

    Original publisher
    Market Ontology
    Evidence through
    2026-10-07
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Neogen Beats Q1 Estimates with $222.8M Revenue and $0.08 Adjusted EPS”, revision 1, evidence through 2026-10-07. https://marketontology.com/market-events/2026-10-07/neogen-beats-q1-estimates-with-222-8m-revenue-and-0-08-adjusted-eps-485d75

    EQUITY
    Neogen Beats Q1 Estimates with $222.8M Revenue and $0.08 Adjusted EPS
    Neogen posted first-quarter fiscal 2026 financial results that surpassed expectations on both top and bottom lines. Net revenue grew 6.5% year-over-year to $222.8 million, beating the $208.09 million consensus estimate by 7.07%. Diluted earnings per share came in at $0.08, delivering a 60% upside surprise relative to the $0.05 consensus estimate. The outperformance reflects strengthening volume trends and integration progress in the Food Safety division.
    NEOG
    Impact
    67
    OCT 7
    SIG
    92%
    NEOG
    Neogen Beats Q1 Estimates with $222.8M Revenue and $0.08 Adjusted EPS
    Neogen posted first-quarter fiscal 2026 financial results that surpassed expectations on both top and bottom lines. Net revenue grew 6.5% year-over-year to $222.8 million, beating the $208.09 million consensus estimate by 7.07%. Diluted earnings per share came in at $0.08, delivering a 60% upside surprise relative to the $0.05 consensus estimate. The outperformance reflects strengthening volume trends and integration progress in the Food Safety division.
    → Operating leverage in Food Safety testing delivers a 60% EPS beat against consensus, driving upward fundamental revisions in NEOG.
    Impact
    Neogen posted first-quarter fiscal 2026 financial results that surpassed expectations on both top and bottom lines. Net revenue grew 6.5% year-over-year to $222.8 million, beating the $208.09 million consensus estimate by 7.07%. Diluted earnings per share came in at $0.08, delivering a 60% upside surprise relative to the $0.05 consensus estimate. The outperformance reflects strengthening volume trends and integration progress in the Food Safety division.
    Affected
    NEOG
    Transmission
    Operating leverage in Food Safety testing delivers a 60% EPS beat against consensus, driving upward fundamental revisions in NEOG.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    NEOGearnings beat and operating margin surprise in core food safety operationsUp1-5dNeogen reported Q1 2026 revenue of $222.8M (vs $208.09M estimate) and EPS of $0.08 (vs $0.05 estimate).

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    NEOGUpagreed11.68 2026-10-07+0.26%PendingPending

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month